SII applies for emergency use authorization of Covid-19 vaccine candidate ‘Covishield’
The Serum Institute of India (SII) has filed an application to the Drugs Controller General of India (DCGI) for emergency use authorization of its potential Covid-19 vaccine candidate ‘Covishield’ SII’s application comes a day after Pfizer India urged for a similar permission for DCGI for Coronavirus vaccine. A senior government official revealed to ANI, “SII…